omniture
logo
Search
DAEWOONG PHARMACEUTICAL
Media Room

Photo News

rss
Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines

Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines

2023-08-16 13:00 2657
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023

Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023

2023-05-19 20:00 2256
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio

Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio

2023-04-28 08:58 2137
Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries

Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries

2023-03-22 21:20 3049
Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

2023-01-31 14:43 3699
Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue

Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue

2022-11-15 20:00 1557
CGBio Signing a North America Out-license Contract on

CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA

2022-08-04 21:00 2383
Daewoong Pharmaceutical Co., Ltd. revs up the growth engine for Nabota, achieving the highest quarterly performance ever

Daewoong Pharmaceutical Co., Ltd. revs up the growth engine for Nabota, achieving the highest quarterly performance ever

2022-07-28 21:00 2530
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

2022-07-20 21:00 1467
CGBIO to introduce AI-empowered robotic intervention device, with clinical trials

CGBIO to introduce AI-empowered robotic intervention device, with clinical trials

2021-09-27 21:00 1669
Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

2021-08-19 21:00 2199
Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment

Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment

2020-09-28 20:00 1953
Daewoong Pharmaceutical Acquires Halal Certification for 'Easyef' through Daewoong Infion

Daewoong Pharmaceutical Acquires Halal Certification for 'Easyef' through Daewoong Infion

2020-05-27 10:00 4409
Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker

Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker

2020-05-11 08:00 5290
Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells

Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells

2020-01-09 09:51 3372